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A B S T R A C T 
Head circumference is the auxological parameter that most correlates with developmental anomalies in 
childhood. Head circumference (HC) two standard deviations (SD) below or above the mean defines 
microcephaly and macrocephaly, respectively. The aim of this retrospective study was to explore 
anthropometric parameters and clinical characteristics among subjects with abnormalities in HC who had 
been referred for developmental assessment. One hundred and sixty four subjects with microcephaly and 144 
subjects with macrocephaly were enrolled from birth to 18 months of age. Head circumference at birth and 
the association with variables related to maternal health status, gestational age, growth pattern, brain imaging 
and clinical characteristics were analyzed. In some cases, an etiological diagnosis was made. In the two 
considered conditions, we found different anthropometric and clinical associations, some of which were 
statistically significant, with implications for ongoing neurodevelopmental surveillance. 
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1. Introduction 
The assessment of growth, considering weight, length or stature and head 
circumference is an integral part of the clinical neonatal and pediatric 
examination (1). Nowadays, prenatal growth monitoring during fetal 
development, mainly assessed by serial ultrasonography, allows the 
neonatologists to better define intrauterine growth patterns in relation to 
gestational age at birth. Fetal growth impairment is defined by the two 
terms Intrauterine Growth Restriction (IUGR) and small for gestational 
age (SGA). These terms are frequently used synonymously, although 
substantial differences exist between them. In fact, IUGR defines a fetus 
that, based on sonographic estimated fetal weight and abdominal 
circumference measurement, has not reached its target weight for a certain 
gestational age (GA). Thus, the fetus shows a progressive reduction in the 
growth percentiles. The term SGA is used for a neonate whose birth 
weight is less than the 10th percentile, while the term adequate for 
gestational age (AGA) is used when birth weight is between the 10th and 
the 90th percentile. The HC is variably affected in relation to the 
symmetric or asymmetric intrauterine growth pattern (2).  
 
 
 
In case of an early onset intrauterine growth impairment (before the third 
trimester of pregnancy) all growth parameters, including HC, are affected, 
while in asymmetrical growth impairment a brain sparing phenomenon 
determines an HC superior to weight in terms of percentiles and z score 
(3,4). 
The HC is the auxological parameter that most correlates with 
developmental abnormalities in childhood. Pediatricians and child 
neuropsychiatrists, when assessing the HC, must consider ethnicity, sex 
and age of the child (5). An HC two standard deviations (SD) below or 
above the mean values, in a referral population, defines microcephaly and 
macrocephaly, respectively. Nevertheless, it should be remembered that 
considering an HC >2 SD below or above the mean, 5% of subjects will 
be microcephalic or macrocephalic, and that a developmental impairment 
will be more frequent when considering an HC >3 SD below or above the 
mean.  
In a clinical setting a differential diagnosis should exclude a 
craniosynostosis, a consequence of a genetically determined premature 
ossification of the fibrous sutures of the skull. The causes of 
microcephaly, can be divided into primary and secondary (6,7). Primary 
microcephaly is related to genetic or chromosomal abnormalities, 
affecting neuronal proliferation and migration.  
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In secondary microcephaly the growth of a normal forming brain is 
impaired by hypoxic-ischemic pathology, infectious disease or inherited 
metabolic disorder. In some instances, an early treatment for a pathology 
identified in the newborn, can really make a difference in terms of 
developmental outcome. Examples of such a favorable condition are 
neonatal antiviral treatment for congenital cytomegalovirus infection 
(CMV) (8) and early individualized treatment after identification of 
inherited metabolic disorders by expanded newborn screening (9). 
Macrocephaly is related to an increased HC. In clinical practice it should 
be considered that apart from cerebral overgrowth, correctly defined as 
megalencephaly, other intracerebral components (increased cerebrospinal 
fluid, cysts of various origin, brain tumors, arteriovenous malformations, 
blood collections) and anomalies of bone skull structures could be 
responsible for an increased HC (10). Thus, detailed monitoring of HC 
should be initiated during pregnancy. Ultrasonography and in selected 
cases fetal MR, will allow a prenatal diagnosis of fetal macrocephaly in 
most cases. At birth, a complete clinical, laboratory and instrumental 
approach will better define the etiology. An early identification of 
treatable conditions such as hydrocephalus, arteriovenous malformations, 
other space occupying lesions and inherited metabolic disorders, provide 
the opportunity to reduce the potential deleterious effects on 
neurodevelopment (9,11). Megalencephaly characterizes several 
congenital conditions and molecular mutations in some cases associated 
with overgrowth syndromes and severe pathological conditions such as 
autism spectrum disorder (12). 
 
2. Methods 
We conducted a retrospective study on 308 subjects enrolled from January 
2003 to June 2019. Inclusion criteria was an abnormal HC in subjects 
referred for suspected developmental delay, whose age ranged from birth 
to 18 months.  
Both microcephalic and macrocephalic subjects were considered in 
relation to the degree of micro or macrocephaly, adopting the value of the 
SD as follows:  
 Microcephaly; HC <2 SD or <3 SD below the mean 
 Macrocephaly; HC >2 SD or >3 SD above the mean 
 Macrocephaly was further analyzed considering two different 
auxological variants defined by the HC percentile/length 
percentile ratio. Relative macrocephaly was defined by a value 
≥ 0.7, and disproportionate macrocephaly by a value < 0.7. 
We performed all statistical analyses with the open source statistical 
software “R” (13). Chi square test was used to test frequency distribution 
of categorical variables within groups of the study. Differences were 
considered statistically significant at p value <0.05. Written informed 
parental consent was obtained for use of the patient's data at the moment 
of the first clinical evaluation. 
3. Results 
Within the whole sample we identified 164 subjects with microcephaly 
and 144 with macrocephaly. Anthropometric and clinical characteristics 
of microcephalic and macrocephalic subjects are shown in Table 1.  
 
 
Table 1. Anthropometric and clinical characteristics of microcephalic 
and macrocephalic subjects. 
 
Microcephalic subjects showed a male sex prevalence (104 males and 60 
females), with an HC at birth ranging from 22.5 to 33.0 cm (2.01 to 3.98 
SD below the mean) and a mean gestational age of 39+3 wks (range 30+0 
to 42+4). A neonatal weight < 10th percentile (SGA) has been identified in 
113/164 subjects (68.9%) while 51/164 subjects (31.1%) were AGA. 
An associated malformation or a genetic syndrome was identified in 21 
subjects, 12.8% (15 males and 6 female). Analyzing the two degrees of 
microcephaly, 144 (86.1%) showed an HC <2 SD below the mean, 17 of 
whom (11.8%) were affected by an associated malformation or a genetic 
syndrome. A degree of microcephaly with HC <3 SD below the mean, 
was found in 20 subjects, 4 of whom (3 males and 1 female) presented 
with an isolated malformation. 
Microcephaly, considering also the two degrees of severity, showed no 
statistically significant association when compared to intrauterine growth 
(AGA vs SGA) gestational age and sex. Nine out of 21 (43%) associated 
malformations, involved the genitourinary tract and only one patient, 
affected by the most severe microcephaly described in the sample, with an 
HC 3.98 SD below the mean, presented with a severe brain malformation 
(schizencephaly).  
Prematurity was present, in 18/164 (11%) subjects with a value superior 
to the Italian prematurity rate (7.79 %), (14). 
A statistically significant association between prematurity and maternal 
pathology was found only in microcephaly with HC <2 SD below the 
mean (p=0.03). 
Cranial ultrasound (US) was useful in the identification of a patient with a 
severe cerebral malformation (schizencephaly), but was less sensitive 
compared to MR in the identification of cerebral calcification evident in 
three newborns with congenital CMV infection. Two patients were 
affected by Smith Magenis syndrome and Ehlers Danlos syndrome.  
Macrocephalic subjects showed a male sex prevalence (81 males and 63 
females), with an HC at birth ranging from 29.5 to 41.0 cm (0.12 to 7.5 
SD above the mean), and a mean gestational age of 38+3 wks (range 26+0 
to 41+6). A neonatal weight > 90th percentile (LGA) was identified in 76 
subjects (52.8%), 67 subjects (46.5%) were AGA, and only one was SGA 
(0.7%). In 12 subjects (15.8%) LGA was related to gestational diabetes, in 
6 (7.9%) to maternal diabetes mellitus and in 5 (6.6 %) to untreated 
maternal hypothyroidism.  Macrocephalic subjects’ prematurity rate was 
11.8% (17/144), superior to the Italian prematurity rate (7.79 %), (14).  
We identified 18/144 patients (12.5%) with associated malformations or 
affected by a genetic syndrome. Congenital heart defects were the most 
frequent malformation detected, affecting 4 patients, while in two patients 
we found a CNS malformation (arachnoid cyst and severe cortical 
dysplasia). 
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Two patients were affected by Pallister Killian syndrome, one by Sotos 
syndrome, one by Greig syndrome and one by a new described Paternal 
Uniparental Disomy involving chromosome 14. Considering the two 
degrees of macrocephaly, 115 (79.9%) showed an HC >2 SD above the 
mean, 14 of whom (12.2%) with an associated malformation or affected 
by a syndrome. A less severe grade of intraventricular hemorrhage, 
without progressive cerebral ventriculomegaly, was found in 4 preterm 
macrocephalic patients and was not surgically treated. Three 
macrocephalic newborns showed a mild ventricular dilatation secondary 
to intrauterine infection (CMV, toxoplasmosis and rubeola). In 15 
subjects, with HC >2 SD above the mean, a benign enlargement of 
subarachnoid spaces was diagnosed by cranial US. Frequent familiarity 
and transitory active tone developmental delay were the hallmarks of this 
condition, confirmed by clinical follow-up and cranial US monitoring.  
Twenty-nine (20.1%) subjects showed an HC >3 SD above the mean, 5 of 
whom (17.3%) with an associated malformation or syndrome (two with 
CNS malformation and one with Sotos syndrome). Two patients showed 
hydrocephalus secondary to intraventricular hemorrhage, one of whom 
with an intrauterine onset. Ventriculoperitoneal shunting was performed 
in both before the age of one month.  
The two auxological variants, relative and disproportionate macrocephaly, 
were defined in 94 subjects with HC between 97th and 99th percentile. A 
relative macrocephaly was identified in 55 (58.5%) subjects (35 males and 
20 females), and was associated with at least one malformation in 7 
(12.7%) subjects, the condition of LGA was prevalent (70.9%) and the 
prematurity rate was 12.8%. A disproportionate macrocephaly was 
identified in 39 (41.5%) subjects (18 males and 21 females), and was 
associated with at least one malformation in 3 (7.7%) subjects, the 
condition of AGA was prevalent (76.3%) and the prematurity rate was 
2,6%. 
No isolated or syndromic macrocephaly showed a statistically significant 
association with abnormal neurological examination (p=0.017), and 
pathological results of cerebral imaging (p=0.041). The disproportionate 
variant of macrocephaly showed a statistically significant association with 
full term birth (p=0.02). 
During the integrated evaluation (neonatologist, pediatric neurologist, 
child neuropsychiatrist, clinical and laboratory geneticist, 
neurophysiologist, radiologist), an etiological diagnosis, one of which has 
never been described before (15), was made in some patients. Three 
newborns with congenital CMV infection were treated with ganciclovir 
and/or valganciclovir. A definite developmental impairment was defined 
for those affected by a genetic syndrome or with severe pathologies 
(cerebral malformations, hydrocephalus, congenital infections with 
neurosensorial involvement), while for many subjects a multidisciplinary 
developmental surveillance, encompassing the neurological, 
neurosensorial, cognitive and behavioral domains, is still ongoing. 
 
4. Discussion 
The aim of the study was to analyze some fetal growth-related parameters 
and clinical characteristics in subjects enrolled for abnormal HC and 
suspected developmental delay. Thus, the sample cannot be considered 
representative of the complex of causes responsible for alterations of the 
HC, being the result of a second-level evaluation, with exclusion of 
subjects with alterations of HC on a family basis and without clinical 
suspicion. 
 
Recent studies on subjects with abnormalities in HC, have mainly focused 
on the association with specific developmental pathologies and related 
adoptable diagnostic criteria (16,17,18), age related growth patterns and 
involved environmental and nutritional factors (19), or 
neurodevelopmental outcome in selected samples of at-risk subjects (20). 
A recent study on subjects aged 5 years from Danish nationwide 
registries, confirmed the association between HC z score and intellectual 
disability in subjects not affected by concomitant malformations and 
congenital syndromes (21).  
In our study, a male sex prevalence for the suspicion of developmental 
delay is present for both conditions. This sex difference has been 
explained by the concept of “female protective model”, which considers 
the higher mutation burden present in females as a protective factor from 
the developmental impairment (22). 
In both conditions we found a similar prematurity rate greater than in the 
reference population. Since prematurity is a well-known risk factor for 
developmental delay, this should be a referral bias. Nevertheless, since an 
increased rate of suboptimal head growth and microcephaly have only 
been described among preterm infants (23), in cases of concomitant 
macrocephaly other predisposing factors should be considered. With this 
in mind, we think that the increased maternal pathology rate detected in 
macrocephalic (21.5%) versus microcephalic (6.7%) newborns should be 
considered. In particular, maternal diabetes mellitus and gestational 
diabetes, pathological conditions responsible for fetal macrosomia (24-
25), have been identified in 23.7% of LGA macrocephalic newborns. 
Macrocephaly with HC >3 SD above the mean, was prevalent (20.1%) in 
comparison to microcephaly with HC <3 SD below the mean (12.8%). We 
attribute this difference to the high level of clinical alertness evoked by an 
increased HC during health and growth monitoring in infancy. Moreover, 
the possible neurological signs associated with macrocephaly, in 
particular axial hypotonia and concomitant positional plagiocephaly, are 
easily detected by pediatricians even without specific training in 
neurology or developmental pediatrics (26).  
Different patterns of intrauterine growth characterized the two conditions 
(microcephaly and macrocephaly) along with a different rate of maternal 
pathology during pregnancy. Microcephaly at birth was predominantly 
associated with the condition of SGA in 68.9% of subjects, and a maternal 
pathology was present in 6.7% of cases. 
Macrocephaly at birth was predominantly associated with the condition of 
LGA in 52.8% of subjects, and a maternal pathology was present in 
21.5% of cases. Thus, a maternal pathology was about 3 times more 
frequent in cases of macrocephaly. Suboptimal treatment of maternal 
pathological conditions such as maternal diabetes mellitus, gestational 
diabetes and hypothyroidism could be considered as the main  factor 
responsible for the high relative rate of clinical referral in our sample. 
A concomitant malformation, was more frequent compared to the normal 
population (2.4 %) for both conditions, and a genetic syndrome was 
diagnosed in 2 subjects with microcephaly and in 5 with macrocephaly 
(27). In these patients it was necessary to plan a surveillance aimed not 
only at monitoring neuro-psychomotor development, but also the 
functional evaluation of the involved organ or apparatus. 
In our study, the results of cerebral imaging showed a statistically 
significant association with neither the isolated nor syndromic 
macrocephaly sub type (p=0.041) and allowed an early diagnosis and 
neurosurgical treatment in two patients with progressive hydrocephalus 
secondary to intraventricular hemorrhage. 
Thus, early cerebral imaging is considered of fundamental importance in 
the assessment of macrocephaly in infancy (10). 
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The relative macrocephaly variant was  more frequently represented than 
the disproportionate one.  
The disproportionate variant of macrocephaly showed a statistically 
significant association with full term birth (p=0.02), and will be included 
in a following study on autism as suggested in recent scientific literature 
(28). 
5. Conclusions 
Strict monitoring of HC, starting from the intrauterine growth assessment, 
is basilar for the early identification and treatment of pathological 
conditions. Also, for those cases in which a diagnosis will require 
prolonged time and resources not always readily available, an 
individualized and multidisciplinary follow up and an early rehabilitation 
intervention will ensure, even in the light of brain plasticity, a better 
functional prognosis. 
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